You are here

Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Augsburg, , 86156 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Possible Fungal Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Acute leukemia, aggressive lymphoma, bone marrow or stem cell transplantation;

- Neutropenia (

- Newly diagnosed fever;

- Positive panfungal polymerase chain reaction assay

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Documented bacterial infection during screening or at randomization

- Fungemia or other documented invasive fungal infection during screening or at
randomization.

NCT00150345
Pfizer
Completed
Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Possible Fungal Infection
NCT00150345
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now